Sarepta Therapeutics' stock plummets after its gene therapy drug ELEVIDYS fails to meet its primary endpoint in a confirmatory study. SRPT had previously secured accelerated approval for ELEVIDYS to ...
As automakers continue to introduce more EVs, public charging is proving unreliable, according to the latest J.D. Power Electric Vehicle Experience Public Charging study. The study found that 20% of ...
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...
New research has uncovered a critical challenge in solar energy with the discovery that a considerable number of solar panels ...
UNESCO warned that the “low prevalence of fact-checking highlights influencers’ vulnerability to misinformation, which can have far-reaching consequences for public trust and discourse.” According to ...
To examine the efficacy of EPA’s label in conveying toxicity information to potential consumers, the researchers conduct an incentivized field experiment with eye tracking to evaluate the ...
NEW YORK, Feb. 23 (UPI) --A new study that compares the label accuracy of a generic drug versus a dietary supplement with the same active pharmaceutical ingredient found that the supplement fared very ...
NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Plus Company, an entrepreneurial network of forward-thinking creative agencies, and Statista, a global data and business intelligence platform, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback